Literature DB >> 28094050

Corruption and use of antibiotics in regions of Europe.

Björn Rönnerstrand1, Victor Lapuente2.   

Abstract

The aim of this article is to investigate the association between corruption and antibiotic use at sub-national level. We explore the correlation between, on the one hand, two measures of corruption (prevalence of corruption in the health sector and prevalence of bribes in the society) at regional level from the European Quality of Government Index; and, on the other, the consumption of antibiotics in those European regions from a 2009 Special Euro Barometer. In a multivariate regression model, we control for potential confounders: purchasing power of standardized regional gross domestic product, inhabitants per medical doctor and age-standardized all-cause mortality rates. We find that there is a strong positive association between both measures of corruption (i.e. in the health sector, and in the society at large) and antibiotics use; and that this association is robust to the introduction of the control variables. These results support previous findings in the literature linking corruption to higher antibiotic use at cross-national level. We show that corruption does seem to account for some of the remarkable between-region variation in antibiotic consumption in Europe.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotic use; Bribery; Corruption; Europe; Regions

Mesh:

Substances:

Year:  2017        PMID: 28094050     DOI: 10.1016/j.healthpol.2016.12.010

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  11 in total

1.  Infection Control in Limited Resources Countries: Challenges and Priorities.

Authors:  Diana Vilar-Compte; Adrián Camacho-Ortiz; Samuel Ponce-de-León
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.725

2.  Thank Martin Luther that ciprofloxacin could cure your gonorrhoea? Ecological association between Protestantism and antimicrobial consumption in 30 European countries.

Authors:  Chris Kenyon; Geoffrey Fatti
Journal:  F1000Res       Date:  2020-10-06

3.  Socioeconomic Enablers for Contagion: Factors Impelling the Antimicrobial Resistance Epidemic.

Authors:  Peter Collignon; John J Beggs
Journal:  Antibiotics (Basel)       Date:  2019-06-30

4.  Who is willing to stay sick for the collective? - Individual characteristics, experience, and trust.

Authors:  Fredrik Carlsson; Gunnar Jacobsson; Sverker C Jagers; Elina Lampi; Felicia Robertson; Björn Rönnerstrand
Journal:  SSM Popul Health       Date:  2019-10-22

5.  Prevention of antibiotic resistance - an epidemiological scoping review to identify research categories and knowledge gaps.

Authors:  Stig Wall
Journal:  Glob Health Action       Date:  2019-12-13       Impact factor: 2.640

6.  Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.

Authors:  Anne Harant
Journal:  Antimicrob Resist Infect Control       Date:  2022-01-24       Impact factor: 4.887

7.  Estimating the effect of practicing nursing professionals density on cumulative carbapenem-resistance prevalence in gram-negative invasive Isolates: a 30 European country observational modeling study.

Authors:  Hani E J Kaba; Simone Scheithauer
Journal:  Antimicrob Resist Infect Control       Date:  2022-02-22       Impact factor: 4.887

8.  Promoting anti-corruption, transparency and accountability in the recruitment and promotion of health workers to safeguard health outcomes.

Authors:  Monica Twesiime Kirya
Journal:  Glob Health Action       Date:  2020       Impact factor: 2.640

Review 9.  Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.

Authors:  Taryn Vian
Journal:  Glob Health Action       Date:  2020       Impact factor: 2.640

10.  Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe.

Authors:  Jane Robertson; Vera Vlahović-Palčevski; Kotoji Iwamoto; Liselotte Diaz Högberg; Brian Godman; Dominique L Monnet; Sarah Garner; Klaus Weist
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.